02002nam a2200409 i 4500001001300000003000300013005001700016007001400033008004100047040003000088042000800118043001200126050001900138074001600157086002700173110007100200245019900271264006000470264010100530300004600631336002600677337002700703338003100730490002300761500003600784500010800820500002500928504004100953533010700994650003301101650003301134650006501167655003301232776014201265776012501407810006001532on1001281992BD20171226114736.0he bmb024bbca170816s2017    dcua    bb   f000 0 eng c  aPUCPRbengerdacGPOdMvI  apcc  an-us---14aKF26b.F5 2016  a1038-B (MF)0 aY 4.F 49:S.HRG.114-5291 aUnited States.bCongress.bSenate.bCommittee on Finance,eauthor.10aExamining the opioid epidemic :bchallenges and opportunities : hearing before the Committee on Finance, United States Senate, One Hundred Fourteenth Congress, second session, February 23, 2016. 1aWashington :bU.S. Government Publishing Office,c2017. 2aWashington, DC :bFor sale by the Superintendent of Documents, U.S. Government Publishing Office  aiii, 119 pages :billustrations ;c24 cm.  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier1 aS. hrg. ;v114-529  aShipping list no.: 2017-0052-M.  aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.  aCRDP Program record.  aIncludes bibliographical references.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2017]e2 microfiches : negative. 0aOpioid abusezUnited States. 0aDrug controlzUnited States. 0aFederal aid to drug abuse treatment programszUnited States. 7aLegislative hearings.2lcgft08iPrint version:aUnited States. Congress. Senate. Committee on Finance.tExamining the opioid epidemicw(DLC) 2017381895w(OCoLC)97233621308iOnline version:aUnited States. Congress. Senate. Committee on Finance.tExamining the opioid epidemicw(OCoLC)9700422801 aUnited States.bCongress.bSenate.tS. hrg. ;v114-529.